Bank of America upgrades Sabra Health Care REIT to buy

Bank of America has upgraded shares of Sabra Health Care REIT to a buy rating from neutral, according to Ticker Report.

Bank of America has a $28.50 target price on the stock. Sabra Health Care has a one-year low of $24.01 and a one-year high of $31.17.

In Sabra Health Care's last available quarterly earnings data, which was issued on July 30, the company reported $0.57 earnings per share for the quarter.

More articles on healthcare finance:

For-profit hospital stock report: Week of Oct. 13-17
Moody's upgrades St. Joseph's Healthcare System's rating to 'Baa3'
How reducing healthcare spending affects economic growth: 4 things to know